256 related articles for article (PubMed ID: 11293923)
1. Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women.
Vartej P; Poiana C; Vartej I
Gynecol Endocrinol; 2001 Feb; 15(1):43-7. PubMed ID: 11293923
[TBL] [Abstract][Full Text] [Related]
2. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for osteoporosis: A review.
Guthrie JR; Dennerstein L; Wark JD
Medscape Womens Health; 2000; 5(4):E1. PubMed ID: 11109046
[TBL] [Abstract][Full Text] [Related]
5. Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women: the ESOPO study.
Adami S; Giannini S; Giorgino R; Isaia GC; Maggi S; Sinigaglia L; Filipponi P; Crepaldi G
Calcif Tissue Int; 2004 Apr; 74(4):317-21. PubMed ID: 15255067
[TBL] [Abstract][Full Text] [Related]
6. Implications of not treating hyperprolactinemia.
Sanfilippo JS
J Reprod Med; 1999 Dec; 44(12 Suppl):1111-5. PubMed ID: 10649820
[TBL] [Abstract][Full Text] [Related]
7. The risk of osteopenia in premenopausal women with various sellar tumors.
Zhao Y; Gan X; Luo P; He Q; Guo Q; Zhang L; Zhang X; Zhang X; Fei Z
Gynecol Endocrinol; 2012 Dec; 28(12):945-8. PubMed ID: 22553947
[TBL] [Abstract][Full Text] [Related]
8. [Decreased bone mineral density in pre-menopause women with prolactinoma].
Bussade I; Naliato EC; Mendonça LM; Violante AH; Farias ML
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1522-7. PubMed ID: 18209896
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
[TBL] [Abstract][Full Text] [Related]
10. Age-associated changes in quantitative ultrasonometry (QUS) of the os calcis in Lebanese women-assessment of a Lebanese reference population.
Wehbe J; Cortbaoui C; Chidiac RM; Nehme A; Melki R; Bedran F; Atallah P; Cooper C; Hadji P; Maalouf G
J Musculoskelet Neuronal Interact; 2003 Sep; 3(3):232-9. PubMed ID: 15758346
[TBL] [Abstract][Full Text] [Related]
11. Prolactinoma in a middle-aged man with an osteoporotic fracture.
Taylor SD; Kelly TM
West J Med; 1989 Jul; 151(1):80-2. PubMed ID: 2763547
[No Abstract] [Full Text] [Related]
12. Vertebral fractures in males with prolactinoma.
Mazziotti G; Porcelli T; Mormando M; De Menis E; Bianchi A; Mejia C; Mancini T; De Marinis L; Giustina A
Endocrine; 2011 Jun; 39(3):288-93. PubMed ID: 21479837
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in premenopausal women with oestrogen deficiency and symptomatic coronary heart disease.
Bruck B; Seitz D; Hanke S; Lange K; Schmah W; Haasis R; Hanke H
Br J Clin Pract; 1996 Dec; 50(8):450-3. PubMed ID: 9039717
[TBL] [Abstract][Full Text] [Related]
14. [Prolactinomas and bone mineral density in men].
Naliato EC; Farias ML; Violante AH
Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):183-95. PubMed ID: 16184246
[TBL] [Abstract][Full Text] [Related]
15. Bone density in women with prolactinoma treated with dopamine agonists.
Naliato EC; Violante AH; Caldas D; Farias ML; Bussade I; Lamounier Filho A; Loureiro CR; Fontes R; Schrank Y; Loures T; Colao A
Pituitary; 2008; 11(1):21-8. PubMed ID: 17661178
[TBL] [Abstract][Full Text] [Related]
16. Measurement of skeletal status after renal transplantation by quantitative ultrasound.
Kosch M; Hausberg M; Link T; Kemkes M; Barenbrock M; Dietl KH; Matzkies F; Rahn KH; Kisters K
Clin Nephrol; 2000 Jul; 54(1):15-21. PubMed ID: 10939752
[TBL] [Abstract][Full Text] [Related]
17. Influence of pregnancy on bone density: a risk factor for osteoporosis? Measurements of the calcaneus by ultrasonometry.
Kraemer B; Schneider S; Rothmund R; Fehm T; Wallwiener D; Solomayer EF
Arch Gynecol Obstet; 2012 Apr; 285(4):907-12. PubMed ID: 21915692
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia Due to Prolactinoma has an Adverse Impact on Bone Health with Predominant Impact on Trabecular Bone: A Systematic Review and Meta-Analysis.
Nagendra L; Dutta D; Mondal S; Kapoor N; Joshi A; Bhattacharya S
J Clin Densitom; 2024; 27(1):101453. PubMed ID: 38064881
[TBL] [Abstract][Full Text] [Related]
19. [Hyperprolactinaemia and bone mineral density].
Kostrzak A; Męczekalski B
Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389
[TBL] [Abstract][Full Text] [Related]
20. Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
Andereggen L; Frey J; Andres RH; Luedi MM; Widmer HR; Beck J; Mariani L; Christ E
Sci Rep; 2021 Mar; 11(1):5122. PubMed ID: 33664388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
